APA Citatie

Troya, J., Montejano, R., Ryan, P., Gómez, C., Matarranz, M., Cabello, A., . . . Valencia, E. (2018). Raltegravir plus abacavir/lamivudine in virologically suppressed HIV-1-infected patients: 48-week results of the KIRAL study. PLoS One.

Chicago Style citaat

Troya, Jesús, et al. "Raltegravir Plus Abacavir/lamivudine in Virologically Suppressed HIV-1-infected Patients: 48-week Results of the KIRAL Study." PLoS One 2018.

MLA citatie

Troya, Jesús, et al. "Raltegravir Plus Abacavir/lamivudine in Virologically Suppressed HIV-1-infected Patients: 48-week Results of the KIRAL Study." PLoS One 2018.